Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8827 |
High Similarity |
NPD8368 |
Discontinued |
0.8667 |
High Similarity |
NPD8407 |
Phase 2 |
0.8563 |
High Similarity |
NPD8434 |
Phase 2 |
0.8462 |
Intermediate Similarity |
NPD8361 |
Approved |
0.8462 |
Intermediate Similarity |
NPD8435 |
Approved |
0.8462 |
Intermediate Similarity |
NPD8360 |
Approved |
0.8276 |
Intermediate Similarity |
NPD8485 |
Approved |
0.8193 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8136 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.8024 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.759 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD8462 |
Phase 1 |
0.7547 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7545 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7542 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7409 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD2629 |
Approved |
0.736 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7192 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7108 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7105 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7105 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7102 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6534 |
Approved |
0.707 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7059 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7039 |
Intermediate Similarity |
NPD6765 |
Approved |
0.6989 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD5401 |
Approved |
0.6977 |
Remote Similarity |
NPD3882 |
Suspended |
0.6977 |
Remote Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD8312 |
Approved |
0.6961 |
Remote Similarity |
NPD8313 |
Approved |
0.6959 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6943 |
Remote Similarity |
NPD7008 |
Discontinued |
0.6936 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6923 |
Remote Similarity |
NPD3226 |
Approved |
0.6923 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7874 |
Approved |
0.691 |
Remote Similarity |
NPD3818 |
Discontinued |
0.6906 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6901 |
Remote Similarity |
NPD1934 |
Approved |
0.6895 |
Remote Similarity |
NPD6781 |
Approved |
0.6895 |
Remote Similarity |
NPD6780 |
Approved |
0.6895 |
Remote Similarity |
NPD6778 |
Approved |
0.6895 |
Remote Similarity |
NPD6782 |
Approved |
0.6895 |
Remote Similarity |
NPD6779 |
Approved |
0.6895 |
Remote Similarity |
NPD6777 |
Approved |
0.6895 |
Remote Similarity |
NPD6776 |
Approved |
0.6892 |
Remote Similarity |
NPD690 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD2532 |
Approved |
0.6886 |
Remote Similarity |
NPD2534 |
Approved |
0.6886 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6886 |
Remote Similarity |
NPD2533 |
Approved |
0.6885 |
Remote Similarity |
NPD6784 |
Approved |
0.6885 |
Remote Similarity |
NPD6785 |
Approved |
0.6875 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6875 |
Remote Similarity |
NPD230 |
Phase 1 |
0.686 |
Remote Similarity |
NPD2801 |
Approved |
0.6857 |
Remote Similarity |
NPD5494 |
Approved |
0.6852 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6848 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD7411 |
Suspended |
0.6833 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6828 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD7741 |
Discontinued |
0.6821 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6802 |
Remote Similarity |
NPD37 |
Approved |
0.6792 |
Remote Similarity |
NPD3764 |
Approved |
0.6788 |
Remote Similarity |
NPD7698 |
Approved |
0.6788 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6788 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6788 |
Remote Similarity |
NPD7697 |
Approved |
0.6786 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6782 |
Remote Similarity |
NPD4965 |
Approved |
0.6782 |
Remote Similarity |
NPD4966 |
Approved |
0.6779 |
Remote Similarity |
NPD5951 |
Approved |
0.6778 |
Remote Similarity |
NPD7054 |
Approved |
0.6768 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6766 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6759 |
Remote Similarity |
NPD5345 |
Clinical (unspecified phase) |
0.6758 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6758 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6753 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6753 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.674 |
Remote Similarity |
NPD7472 |
Approved |
0.6735 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6735 |
Remote Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.6735 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6727 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6717 |
Remote Similarity |
NPD7801 |
Approved |
0.6712 |
Remote Similarity |
NPD2182 |
Approved |
0.6711 |
Remote Similarity |
NPD6010 |
Discontinued |
0.6707 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6705 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6689 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6647 |
Remote Similarity |
NPD1512 |
Approved |
0.6647 |
Remote Similarity |
NPD3750 |
Approved |
0.6647 |
Remote Similarity |
NPD6273 |
Approved |
0.6646 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6646 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.663 |
Remote Similarity |
NPD7228 |
Approved |
0.6629 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6628 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6626 |
Remote Similarity |
NPD6651 |
Approved |
0.6623 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6623 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6623 |
Remote Similarity |
NPD5126 |
Approved |
0.6621 |
Remote Similarity |
NPD5048 |
Discontinued |
0.6615 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6611 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6606 |
Remote Similarity |
NPD6100 |
Approved |
0.6606 |
Remote Similarity |
NPD2796 |
Approved |
0.6606 |
Remote Similarity |
NPD6099 |
Approved |
0.6601 |
Remote Similarity |
NPD9545 |
Approved |
0.6601 |
Remote Similarity |
NPD6319 |
Approved |
0.6591 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6588 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6587 |
Remote Similarity |
NPD2800 |
Approved |
0.6585 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6581 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6579 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6579 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6579 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6576 |
Remote Similarity |
NPD5030 |
Phase 2 |
0.6571 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6566 |
Remote Similarity |
NPD5762 |
Approved |
0.6566 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD7266 |
Discontinued |
0.6566 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6566 |
Remote Similarity |
NPD5763 |
Approved |
0.6566 |
Remote Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.6564 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6562 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6556 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6554 |
Remote Similarity |
NPD3749 |
Approved |
0.6554 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6552 |
Remote Similarity |
NPD1237 |
Approved |
0.6548 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6548 |
Remote Similarity |
NPD7003 |
Approved |
0.6548 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6545 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6545 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6545 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6541 |
Remote Similarity |
NPD36 |
Approved |
0.6541 |
Remote Similarity |
NPD5034 |
Approved |
0.6541 |
Remote Similarity |
NPD6085 |
Phase 2 |
0.6541 |
Remote Similarity |
NPD4955 |
Approved |
0.6541 |
Remote Similarity |
NPD4954 |
Approved |
0.6541 |
Remote Similarity |
NPD5028 |
Approved |
0.6541 |
Remote Similarity |
NPD5026 |
Approved |
0.6541 |
Remote Similarity |
NPD5740 |
Clinical (unspecified phase) |
0.6538
|
Remote Similarity |
NPD4807 |
Approved |